Lupus nephritis, preeclampsia, C3, C4 complement components, hypertension, anti-Ro, anti-La, aPL antibodies, SLE flares, age, disease activity, duration, and IV cyclo-therapy were evaluated as potential predictors. This evidence concerns the gene CALR and lupus nephritis.